MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-18-0058009
Market Cap
₹601 Cr
INFLUX-SM · NSE
Share Price
₹262.65
+1.21% today
Revenue
₹147 Cr
FY 2025-26 · +40.0% YoY
EBITDA
₹29.86 Cr
Margin 20.3%
Net Profit
₹20.54 Cr
FY 2025-26 · +53.6% YoY
P/E (TTM)
31.4x
P/B 6.0x
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹23.15 Cr
Issued & subscribed
About Influx Healthtech Limited
Data last updated:
Influx Healthtech Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L24299MH2020PLC346825. Its GSTIN is 27AAFCI8246N1ZY (Maharashtra). Its shares are listed on NSE: INFLUX.
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹23.15 Cr. It was formerly known as Influx Healthtech Private Limited. It is led by directors including Munir Abdul Ganee Chandniwala (Managing Director) and Shirin Munir Ahmed Chandniwala (Whole-Time Director).
Its last annual general meeting (AGM) was held on 18 September 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 109 Ghanshyam Enclave Premises Co – Op Soc Plot No. 856 Laljipada Kandivali West, Mumbai, Maharashtra, India – 400067.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹146.83 Cr, a growth of 40% compared to the previous year. For the same year it recorded a net profit of ₹20.54 Cr (net margin 14%) and EBITDA of ₹29.86 Cr (EBITDA margin 20.3%). The net worth stands at ₹100.76 Cr (up 178.7% YoY). Total assets are valued at ₹100.99 Cr (up 176% YoY).
The company has about 160 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Influx Healthtech. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it; 2 cases are pending. The company has 1 deal on record (1 ipo); the latest was in June 2025. Its 10 peer companies in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Meridian Chem-Bond Private Limited with revenue of ₹105.28 Cr. The company has 6 MSME Form 1 returns on record between 2022 and 2023, listing 347 overdue payments to 23 micro and small suppliers.
Influx Healthtech Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0058009). For more details, the company can be reached via its website influxhealthtech.com.
Company Details of Influx Healthtech Limited
CIN L24299MH2020PLC346825
Registration Number 346825
Incorporation Date 28 September 2020
ROC Mumbai
Listing Status Listed (NSE: INFLUX)
Company Status Active
Date of Last AGM 18 September 2026
Date of Balance Sheet 31 March 2026
MSME Classification Medium
Udyam Registration UDYAM-MH-18-0058009
CIN History of Influx Healthtech Limited
Influx Healthtech has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24299MH2020PLC346825, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24299MH2020PLC346825 | Current |
| U24299MH2020PLC346825 | Previous |
| U24299MH2020PTC346825 | Previous |
Key People
Munir Abdul Ganee Chandniwala Managing Director Shirin Munir Ahmed Chandniwala Whole-Time Director Abdul Ganee Abdul Rasul Chandniwala Director Recognitions & Rankings of Influx Healthtech
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address109 Ghanshyam Enclave Premises Co – Op Soc Plot No. 856 Laljipada Kandivali West, Mumbai, Maharashtra, India – 400067
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Influx Healthtech Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Influx Healthtech Limited
Influx Healthtech operates one associated brand: Influx Healthtech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Contract based manufacturer of healthcare products | influxhealthtech.com |
Business Activity of Influx Healthtech Limited
The main business activity of Influx Healthtech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Influx Healthtech Limited FY 2025-26 filings available
Influx Healthtech Limited reported revenue of ₹146.83 Cr (up 40% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue
₹147 Cr
+40.0% YoY
EBITDA
₹29.86 Cr
+45.1% YoY
Profit After Tax
₹20.54 Cr
+53.6% YoY
Net Worth
₹101 Cr
+178.7% YoY
Total Assets
₹101 Cr
+176.0% YoY
Total Debt
Nil
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | 147 | 105 | 99.97 | 76.06 | 59.22 | 0.00 |
| Revenue growth | +40.0% | +4.9% | +31.4% | +28.4% | - | - |
| EBITDA | 29.86 | 20.58 | 16.97 | 10.75 | 6.24 | 0.00 |
| EBITDA margin | +20.3% | +19.6% | +17.0% | +14.1% | +10.5% | - |
| Profit before tax | 27.23 | 17.88 | 14.95 | 9.75 | 6.08 | 0.00 |
| Net profit | 20.54 | 13.37 | 11.15 | 7.21 | 4.51 | 0.00 |
| Net profit margin | +14.0% | +12.8% | +11.2% | +9.5% | +7.6% | - |
| EPS (₹) | 9.35 | 7.36 | 4,451.20 | 2,878.52 | 1,801.91 | (1.75) |
| Balance sheet | ||||||
| Total assets | 101 | 36.59 | 23.44 | 12.67 | 5.14 | 0.02 |
| Net worth | 101 | 36.15 | 22.78 | 11.66 | 4.53 | 0.03 |
| Total debt | 0.00 | 0.22 | 0.32 | 0.80 | 0.61 | 0.00 |
| Cash & bank | 25.16 | 1.91 | 3.61 | 3.55 | 1.47 | 0.02 |
| Net working capital | 56.45 | 15.32 | 8.03 | 4.44 | 1.88 | 0.02 |
| Cash flow | ||||||
| Cash from operations | 3.89 | 7.06 | 8.94 | 6.82 | 4.29 | 0.00 |
| Cash from investing | (25.17) | (8.64) | (8.36) | (4.88) | (3.41) | 0.00 |
| Cash from financing | 44.53 | (0.11) | (0.53) | 0.14 | 0.56 | 0.03 |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 21 Oct 2026
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Revenue | 147 | 105 | 99.97 | 76.06 | 59.22 | 0.00 |
| Revenue growth | +40.0% | +4.9% | +31.4% | +28.4% | - | - |
| Other income | 1.33 | 0.13 | 0.05 | 0.00 | 0.00 | 0.00 |
| Total expenses | 117 | 84.27 | 83.00 | 65.31 | 52.98 | 0.00 |
| Employee cost | 0.00 | 7.79 | 6.44 | 4.62 | 3.20 | 0.00 |
| EBITDA | 29.86 | 20.58 | 16.97 | 10.75 | 6.24 | 0.00 |
| EBITDA margin | +20.3% | +19.6% | +17.0% | +14.1% | +10.5% | - |
| Depreciation | 3.78 | 2.82 | 1.85 | 0.94 | 0.12 | 0.00 |
| Interest | 0.18 | 0.01 | 0.22 | 0.06 | 0.04 | 0.00 |
| Profit before tax | 27.23 | 17.88 | 14.95 | 9.75 | 6.08 | 0.00 |
| Tax | 6.69 | 4.51 | 3.80 | 2.54 | 1.57 | 0.00 |
| Net profit | 20.54 | 13.37 | 11.15 | 7.21 | 4.51 | 0.00 |
| Net profit margin | +14.0% | +12.8% | +11.2% | +9.5% | +7.6% | - |
| EPS (₹) | 9.35 | 7.36 | 4,451.20 | 2,878.52 | 1,801.91 | (1.75) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Equity & liabilities | ||||||
| Share capital | 23.15 | 18.15 | 0.03 | 0.03 | 0.03 | 0.03 |
| Reserves & surplus | 77.61 | 18.00 | 22.75 | 11.63 | 4.50 | 0.00 |
| Shareholders' funds (net worth) | 101 | 36.15 | 22.78 | 11.66 | 4.53 | 0.03 |
| Secured loans | 0.00 | 0.00 | 0.03 | 0.08 | 0.12 | 0.00 |
| Unsecured loans | 0.00 | 0.22 | 0.29 | 0.72 | 0.49 | 0.00 |
| Total debt | 0.00 | 0.22 | 0.32 | 0.80 | 0.61 | 0.00 |
| Total liabilities | 101 | 36.59 | 23.44 | 12.67 | 5.14 | 0.02 |
| Assets | ||||||
| Gross block | 37.10 | 24.50 | 16.64 | 7.39 | 2.86 | 0.00 |
| Net block | 27.58 | 18.76 | 13.73 | 6.33 | 2.74 | 0.00 |
| Capital work in progress | 3.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 2.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 15.93 | 13.22 | 5.46 | 1.96 | 1.75 | 0.00 |
| Sundry debtors | 33.78 | 32.44 | 15.92 | 13.83 | 10.31 | 0.00 |
| Cash & bank balances | 25.16 | 1.91 | 3.61 | 3.55 | 1.47 | 0.02 |
| Loans & advances | 4.29 | 1.45 | 0.70 | 0.73 | 0.77 | 0.00 |
| Total current assets | 79.16 | 49.02 | 25.69 | 20.07 | 14.30 | 0.02 |
| Total current liabilities | 22.71 | 33.70 | 17.66 | 15.63 | 12.42 | 0.00 |
| Net working capital | 56.45 | 15.32 | 8.03 | 4.44 | 1.88 | 0.02 |
| Total assets | 101 | 36.59 | 23.44 | 12.67 | 5.14 | 0.02 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Opening cash | 1.91 | 3.61 | 3.55 | 1.47 | 0.02 | 0.00 |
| Net cash from operating activities | 3.89 | 7.06 | 8.94 | 6.82 | 4.29 | 0.00 |
| Net cash from investing activities | (25.17) | (8.64) | (8.36) | (4.88) | (3.41) | 0.00 |
| Net cash from financing activities | 44.53 | (0.11) | (0.53) | 0.14 | 0.56 | 0.03 |
| Net change in cash | 23.25 | (1.70) | 0.06 | 2.08 | 1.44 | 0.02 |
| Closing cash | 25.16 | 1.91 | 3.61 | 3.55 | 1.47 | 0.02 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Growth | ||||||
| Sales growth | +40.0% | +4.9% | +31.4% | +28.4% | - | - |
| EBITDA growth | +45.1% | +21.3% | +57.9% | +72.3% | - | - |
| PBT growth | +52.3% | +19.6% | +53.3% | +60.4% | +9997.0% | +9997.0% |
| Net income growth | +53.6% | +19.9% | +54.7% | +59.9% | - | - |
| Revenue CAGR (3Y) | +24.5% | +21.0% | - | - | - | - |
| EBITDA CAGR (3Y) | +40.6% | +48.9% | - | - | - | - |
| Profitability & leverage | ||||||
| Net income margin | +14.0% | +12.8% | +11.2% | +9.5% | +7.6% | - |
| Return on capital employed | - | +59.6% | +83.9% | +110.1% | +236.4% | 0.0% |
| Return on net worth | - | +45.4% | +64.6% | +88.9% | +197.4% | 0.0% |
| Debt / equity | - | 0.01 | 0.03 | 0.09 | 0.13 | 0.00 |
| Long-term debt / equity | - | 0.00 | 0.00 | 0.04 | 0.12 | 0.00 |
| Interest cover | 0.69 | 0.06 | 1.46 | 0.61 | 0.65 | - |
| Efficiency & per share | ||||||
| Fixed asset turnover | - | 5.10 | 8.32 | 14.84 | 48.66 | 0.00 |
| Inventory turnover | - | 11.23 | 26.95 | 41.00 | 79.53 | 0.00 |
| Debtors turnover | - | 4.34 | 6.72 | 6.30 | 13.50 | 0.00 |
| EPS (₹) | 9.35 | 7.36 | 4,451.20 | 2,878.52 | 1,801.91 | (1.75) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 19.91 | 9,111.76 | 4,660.60 | 1,810.16 | 8.25 |
Want more history and ratios?
You're viewing the latest exchange-filed financials for Influx Healthtech Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
Board of Directors of Influx Healthtech Limited
Influx Healthtech has 5 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Munir Abdul Ganee Chandniwala Also directs: Eslp Digital LLP, Olahey Wellness Private Limited, Trusan Printpack Private Limited and 2 more | Managing Director | 28 Sep 2020 | 6 Years 0 Months | Current |
| Shirin Munir Ahmed Chandniwala | Whole-Time Director | 28 Sep 2020 | 6 Years 0 Months | Current |
| Abdul Ganee Abdul Rasul Chandniwala | Director | 18 Apr 2022 | 4 Years 6 Months | Current |
| Mohmad Saleh Mutvalli Also directs: Jamnagar Renewables Two Private Limited, Jamnagar Renewables Private Limited, Srijan Energy Systems Private Limited and 5 more | Director | 31 Mar 2026 | 0 Years 6 Months | Current |
| Vipul Balubhai Patel Also directs: Sunflower Laboratory Private Limited | Director | 13 Jul 2024 | 2 Years 3 Months | Current |
Peer Comparison of Influx Healthtech Limited
Influx Healthtech Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Influx Healthtech Limited this company | ₹146.83 Cr (FY 2026) | •••• | •••• | 40.0% | •••• | Mumbai, Maharashtra, India |
| Meridian Chem-Bond Private Limited | ₹105.28 Cr (FY 2025) | •••• | •••• | 58.0% | •••• | Mumbai, Maharashtra, India |
| Mediforce Healthcare Private Limited | ₹105.22 Cr (FY 2024) | •••• | •••• | 22.0% | •••• | Meerut, Uttar Pradesh, India |
| Vector Biotek Private Limited | ₹105.13 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Navsari, Gujarat, India |
| Warkem Biotech Private Limited | ₹105.06 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Thane, Maharashtra, India |
| Indovax Private Limited | ₹105 Cr (FY 2024) | •••• | •••• | 6.0% | •••• | New Delhi, Delhi, India |
| Hygiene Plus Limited | ₹104.86 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Dadri, Uttar Pradesh, India |
| Modi-Mundipharma Beauty Products Private Limited | ₹104.83 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | New Delhi, Delhi, India |
| Fortune Healthcare Product Private Limited | ₹104.81 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | Vadodara, Gujarat, India |
| Synergy Ethyl Private Limited | ₹104.75 Cr (FY 2025) | •••• | •••• | 69.0% | •••• | Hoshiarpur, Punjab, India |
| Yogesh Dyestuff Products Private Limited | ₹104.58 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Influx Healthtech by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Influx Healthtech Limited
Influx Healthtech Limited is audited by Phirodia Bafna & Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Phirodia Bafna & Associates | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Shareholding Pattern of Influx Healthtech Limited
Shareholding for the quarter ended Sep 2026: promoters hold 73.50%, foreign institutional investors hold 0.20%, domestic institutional investors hold 5.60% and retail and other public shareholders hold 20.70%.
Sep 2026
QUARTER
73.50% Promoters
5.60% DII (Domestic Institutional)
0.20% FII (Foreign Institutional)
20.70% Retail & Others
Promoter holding - history
Now 73.50% · Sep 2026High 73.50% · Mar 2026Low 73.50% · Mar 2026
Shareholding trend - last 6 quarters
| Sep 2026 | Jun 2026 | Mar 2026 | |
|---|---|---|---|
| Promoters | 73.50% | 73.50% | 73.50% |
| Public | 26.50% | 26.50% | 26.50% |
Charges & Borrowings of Influx Healthtech Limited
Influx Healthtech Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding of Influx Healthtech Limited
Influx Healthtech Limited has 1 deal on record (1 ipo); the latest was in June 2025.
Total deals
1
IPO
1
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2025 | IPO | ₹55.63 Cr | Investors: CCV Emerging Opportunities Fund, Finavenue Capital Trust, Craft Emerging Market Fund Seller: an individual |
Premium access
Full deal history
All 1 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Influx Healthtech Limited
Influx Healthtech Limited has 2 court cases on record: 1 filed by Influx Healthtech, 1 filed against it. All cases are pending. Status as checked between 21 Sep 2026 and 29 Sep 2026.
Total cases
2
Filed by the company
1
Filed against the company
1
Pending
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 1 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Cases) | Filed by the company against Aqwina Healthcare Private Limited | Pending |
| District court, Thane, Maharashtra | Civil suit | Filed against the company by Food Safety and Standards Authority of India | Pending |
Premium access
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Influx Healthtech Limited
Influx Healthtech Limited has 6 MSME Form 1 returns on record between 2022 and 2023, listing 347 overdue payments to 23 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 23)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Wincoat Colours and Coatings Private Limited | •••• | •••• | •••• |
| Herbo Nutra Extract Private Limited | •••• | •••• | •••• |
| Arjuna Natural Private Limited | •••• | •••• | •••• |
| Bipin Offset Limited | •••• | •••• | •••• |
| Chemkart India Limited | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 6 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Influx Healthtech Limited
Influx Healthtech Limited has a workforce of 160 employees as of Apr 05, 2024.
Employee count
160
Active EPFO establishments
1
Employee growth
12.68%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Influx Healthtech Limited
Influx Healthtech Limited has 14 board changes on record since 2020: 8 appointments and 6 cessations. The latest: Mohmad Saleh Mutvalli was appointed as Director on 31 Mar 2026.
AGM
Influx Healthtech Limited last Annual general meeting of members was held on 18 Sep 2026 as per latest MCA records.
Filing
Influx Healthtech Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai I.
Appointed
Mohmad Saleh Mutvalli was appointed as Director.
Ceased
Ashok Kumar Jain ceased to be Additional Director.
Ceased
Munir Abdul Ganee Chandniwala ceased to be Director.
Appointed
Ashok Kumar Jain was appointed as Director.
Ceased
Shirin Munir Ahmed Chandniwala ceased to be Director.
Appointed
Vipul Balubhai Patel was appointed as Director.
Ceased
Mohmad Saleh Mutvalli ceased to be Director.
Ceased
Vipul Balubhai Patel ceased to be Director.
Appointed
Ashish Ghanshyambhai Shah was appointed as CFO.
Appointed
Atul Kumar Ashok Kumar Shukla was appointed as Company Secretary.
5 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Influx Healthtech Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Influx Healthtech Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Influx Healthtech Limited
Influx Healthtech has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCI8246N1ZY | Maharashtra | Active | 30 Nov 2020 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Influx Healthtech Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Influx Healthtech Limited
Frequently Asked Questions about Influx Healthtech Limited
Influx Healthtech is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 September 2020 (6+ years old) and is registered under CIN L24299MH2020PLC346825. Listed on NSE: INFLUX.
Influx Healthtech reported revenue of ₹146.83 Cr for FY 2025-26 (up 40% YoY) based on standalone financials.
Influx Healthtech has 5 current directors:
- Munir Abdul Ganee Chandniwala - Managing Director
- Shirin Munir Ahmed Chandniwala - Whole-Time Director
- Abdul Ganee Abdul Rasul Chandniwala - Director
- Mohmad Saleh Mutvalli - Director
- Vipul Balubhai Patel - Director
The GSTIN of Influx Healthtech is 27AAFCI8246N1ZY, registered in Maharashtra.
The CIN (Corporate Identification Number) of Influx Healthtech is L24299MH2020PLC346825. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Influx Healthtech is listed on NSE with symbol INFLUX.
Influx Healthtech has 2 court cases on record: 1 filed by the company and 1 filed against it. 2 are pending.
Influx Healthtech was incorporated on 28 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Influx Healthtech has 1 deal on record (1 ipo); the latest was in June 2025.
The peers of Influx Healthtech by revenue are Meridian Chem-Bond Private Limited, Mediforce Healthcare Private Limited, Vector Biotek Private Limited, Warkem Biotech Private Limited, Indovax Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mohmad Saleh Mutvalli was appointed as Director on 31 Mar 2026. Ashok Kumar Jain ceased to be Additional Director on 29 Jul 2024. Munir Abdul Ganee Chandniwala ceased to be Director on 29 Jul 2024. Influx Healthtech has 14 board changes on record in total.
Yes, Influx Healthtech is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-18-0058009).